[HTML][HTML] Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients

M Kannan, P Sathiyarajeswaran, D Sasikumar… - Journal of Ayurveda and …, 2022 - Elsevier
Abstract Background The Coronavirus disease 2019 (COVID-19) pandemic caused by the
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a massive threat to …

[PDF][PDF] COVID-19 PANDEMIC IMPACTS ON DAY TO-DAY-LIFE: A MINI

S Ghosh, A Porey - 2022 - researchgate.net
Covid19 is a major threat to worldwide and still now no such prophylaxis as well as
therapeutically proven medication not be available and is considered a pandemic by World …

Documentation, Clinical Validation, Safety Assessment and Efficacy of Siddha Treatment in COVID 19 SARS-CoV-2: A Case Series

J Jeyavenkatesh, P Saravanapandian… - Journal of …, 2021 - ebooks.netkumar1.in
Aims: To evaluate clinical validation, safety assessment and efficacy of Siddha line of
treatment in COVID-19 patients. Presentation of the Case: Open labelled, interventional …

[PDF][PDF] STANDARDIZATION OF AMUKKARA CHOORANUM-SIDDHA DRUG

K Saravanan, S Venugopal, R Shilpa - researchgate.net
Siddha medicine originated from Tamil culture in southern India. Worldwide there are 75%
of herbal plants are used for AYUSH and Allopathy medicines. Amukkara Choornam is a …